Skip to main content
Logo GMV

Main navigation

  • Sectors
    • Icono espacio
      Space
    • Icono Aeronáutica
      Aeronautics
    • Icono Defensa y Seguridad
      Defense and Security
    • Icono Sistemas Inteligentes de Transporte
      Intelligent Transportation Systems
    • Icono Automoción
      Automotive
    • Icono Ciberseguridad
      Cybersecurity
    • Icono Servicios públicos Digitales
      Digital Public Services
    • Icono Sanidad
      Healthcare
    • Icono Industria
      Industry
    • Icono Financiero
      Financial
    • Icono Industria
      Services
    • All Sectors

    Highlight

    Inteligencia de datos en defensa
    Data intelligence for decision-making in hybrid warfare environments
  • Talent
  • About GMV
    • Get to Know the Company
    • History
    • Management Team
    • Certifications
    • Sustainability
  • Communication
    • News
    • Events
    • Blog
    • Magazine GMV News
    • Press Room
    • Media library
    • Latest from GMV

Secondary navigation

  • Products A-Z
  • GMV Global
    • Global (en)
    • Spain and LATAM (es - ca - en)
    • Germany (de - en)
    • Portugal (pt - en)
    • Poland (pl - en)
    • All branches and all GMV sites
  • Home
  • Communication
  • News
Back
New search
Date
  • Healthcare

La Luz, Spain´s first private hospital to take up the worlds´s first simulator capable of forecasting the effect of intraoperative radiotherapy

28/05/2012
Share

Clínica La Luz, Spain´s first private hospital to take up the worlds´s first simulator capable of forecasting the effect of intraoperative radiotherapy
Clínica La Luz in Madrid has become Spain’s first private hospital to take up the new intraoperative radiation therapy planner radiance™. This virtual simulator is a world first, forecasting the effect of radiation therapy on tissues, planning the irradiation zone in a precise way and thus avoiding any damage to surrounding healthy tissue.

Specialists in intraoperative radiotherapy of tumors can now work from a more complete patient analysis for decision-taking before the surgery goes ahead, helping to identify the best possible treatment for each particular case.

radiance™ has been developed by the Spanish group GMV in collaboration with a research team led by the Hospital Universitario Gregorio Marañón and a set of prestigious Spanish hospitals and universities.

Since 2001, when radiation oncology started in La Luz, the clinic has been providing an intraoperative radiation therapy service in its unit; this in itself bears out its experience in this technique. This planner now makes La Luz a worldwide trailblazer among all the other hospitals offering this subspecialism and also the first private clinic in Spain to buy this simulator.

Radiation therapy is a type of oncology treatment that uses ionizing radiation to destroy, inactivate and control the tumor cells. Radiation therapy, together with surgery and chemotherapy, is one of the three pillars of cancer treatment today. It is estimated that over 50% of cancer patients will need radiation therapy for tumor control or as palliative therapy at some moment during the disease.

Intraoperative radiation therapy is a technique for directing a single high-intensity radiation dose at the tumor bed during surgery, immediately after extirpation of the tumor, or at any residual disease, protecting the surrounding radiation-sensitive healthy tissue and organs. This technique reduces the recurrence risk of many types of tumor such as rectum cancer, sarcomas, breast cancer, etc, and improves the curative chances of locally recurrent cancer. It has an important palliative effect in other types of hard-to-treat cancers such as pancreas cancer.

Intraoperative radiation therapy also cuts down treatment time and the number of hospital visits in certain cases such as early breast cancer, in which it can partially or even totally replace external radiotherapy, reducing the overall treatment time by up to 6 weeks. It might even become the exclusive oncology treatment in certain cases. This type of radiotherapy can also minimize the secondary effects on healthy tissue (chronic sequels) and therefore optimizes the use of healthcare resources.

Share

Related

Cesión al Hospital Universitario de Bellvitge de SEPI-IA, prototipo para mejorar con IA el diagnóstico de enfermedades pulmonares, gracias a tecnología de GMV
  • Healthcare
News
Bellvitge Hospital receives SEPI-IA, GMV’s prototype for lung disease diagnosis
Inforsalud 2026
  • Healthcare
Inforsalud 2026
24 Mar - 26 Mar

9:30 AM to 7:00 PM

La IA aplicada al cuidado de la Salud en 2026
  • Healthcare
AI applied to healthcare in 2026
23 Mar

10:15 AM to 2:30 PM

Contact

Alameda dos Oceanos, 115
1990-392 Lisbon, Portugal

Tel. +351 308801495
Fax. +351 213866493

Contact menu

  • Contact
  • GMV around the world

Blog

  • Blog

Sectors

Sectors menu

  • Space
  • Aeronautics
  • Defense and Security
  • Intelligent Transportation Systems
  • Automotive
  • Cybersecurity
  • Digital Public Services
  • Healthcare
  • Industry
  • Financial
  • Services
  • Talent
  • About GMV
  • Shortcut to
    • Press Room
    • News
    • Blog
    • Products A-Z
© 2026, GMV Innovating Solutions S.L.

Footer menu

  • Contact
  • Legal Notice
  • Privacy Policy
  • Cookie Policy

Footer Info

  • Commitment to the Environment
  • Financial Information